TSLA
Tesla
-- 431.660 RGTI
Rigetti Computing
-- 17.0800 NVDA
NVIDIA
-- 137.010 LAES
SEALSQ Corp
-- 9.080 PLTR
Palantir
-- 79.080 
Despite a high P/S ratio, Hebei Changshan Biochemical Pharma...
Despite a high P/S ratio, Hebei Changshan Biochemical Pharmaceutical's recent poor growth signals potential investor risk. High P/S ratio, alongside declining revenues, may indicate overvaluation and potential disappointment for shareholders.
Investor Optimism Abounds Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) But Growth Is Lacking
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment